# A Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma Patients

> **NCT03600363** · PHASE2 · UNKNOWN · sponsor: **Ruijin Hospital** · enrollment: 250 (estimated)

## Conditions studied

- Lymphoma, Large B-Cell, Diffuse
- Stage III Follicular Lymphoma

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT03600363
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-01
- **Primary completion:** 2021-01
- **Final completion:** 2021-12
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2020-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03600363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03600363, "A Clinical Trial of Metformin in the Maintenance of Non-Hodgkin's Lymphoma Patients". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT03600363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*